Literature DB >> 23217875

Surgical strategies for unresectable hepatoblastomas.

Tatsuro Tajiri1, Osamu Kimura, Shigehisa Fumino, Taizo Furukawa, Tomoko Iehara, Ryota Souzaki, Yoshiaki Kinoshita, Yuhki Koga, Aiko Suminoe, Toshiro Hara, Kenichi Kohashi, Yoshinao Oda, Tomoro Hishiki, Hajime Hosoi, Eiso Hiyama, Tomoaki Taguchi.   

Abstract

BACKGROUND: The aim of this study was to assess the surgical strategies for unresectable hepatoblastomas at the initial diagnosis based on the experience of two institutions.
METHODS: The PRETEXT (Pretreatment evaluation of tumor extent) and POST-TEXT (Post treatment extent of disease) staging, surgical treatments, and clinical outcomes were retrospectively analyzed for 12 cases with PRETEXT III or IV and M(-) of 29 hepatoblastomas treated based on the JPLT-2 (The Japanese Study Group for Pediatric Liver Tumor-2) protocol at two institutions between 1998 and 2011.
RESULTS: Two of the 9 cases with PRETEXT III status were downstaged to POST-TEXT II. One of the 3 cases with PRETEXT IV showed downstaging to POST-TEXT III. Four of the 7 cases with P2 or V3 (indicated for liver transplantation) in the PRETEXT staging system showed P2 or V3 in POST-TEXT staging after 2 cycles of CITA (JPLT-2 standard regimen), and one case showed P2 or V3 in POST-TEXT staging at the initial operation and underwent primary liver transplantation. The initial surgical treatments were 1 lobectomy, 2 segmentectomies, 6 trisegmentectomies, 2 mesohepatectomies, and 1 primary liver transplantation. Both patients who underwent mesohepatectomies had bile leakage, and 1 of 5 trisegmentectomies had an acute obstruction of the right hepatic vein. Two patients underwent rescue living donor liver transplantation. Both of these patients showed P2 or V3 positive findings in POST-TEXT staging after 2 cycles of CITA.
CONCLUSIONS: POST-TEXT staging and P and V factors should be evaluated after 2 cycles of CITA for unresectable hepatoblastomas detected at the initial diagnosis. The patients should be referred to the transplantation center if the POST-TEXT IV, P2, or V3 is positive at that time. Liver resection by trisegmentectomy is recommended in view of the incidence of surgical complications. Careful treatment, such as back-up transplantation, should thus be considered for liver resection in the cases with POST-TEXT IV, P2, or V3 status after initial 2 cycles of CITA.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23217875     DOI: 10.1016/j.jpedsurg.2012.09.006

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).

Authors:  Eiso Hiyama; Yuka Ueda; Yoshiyuki Onitake; Shou Kurihara; Kenichiro Watanabe; Tomoro Hishiki; Tatsuro Tajiri; Komei Ida; Michihiro Yano; Satoshi Kondo; Takaharu Oue
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

2.  Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.

Authors:  Xianghai Ren; Haibo Li; Mei Diao; Hang Xu; Long Li
Journal:  Int J Clin Oncol       Date:  2019-11-07       Impact factor: 3.402

Review 3.  Indications, limitations and maneuvers to enable extended hepatectomy: current trends.

Authors:  Dimitrios Dimitroulis; Petros Tsaparas; Serena Valsami; Dimitrios Mantas; Eleftherios Spartalis; Charalampos Markakis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  Changes in the indications for living donor liver transplantation: single-institution experience of 3,145 cases over 10 years.

Authors:  Sang-Hyun Kang; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Jung-Man Namgoong; Young-In Yoon; Hui-Dong Cho; Jae-Hyun Kwon; Yong-Kyu Chung; Jin-Uk Choi; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2020-03-31

Review 5.  Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.

Authors:  Taizo Hibi; Osamu Itano; Masahiro Shinoda; Yuko Kitagawa
Journal:  Surg Today       Date:  2016-04-29       Impact factor: 2.549

Review 6.  Current therapeutic strategies for childhood hepatic tumors: surgical and interventional treatments for hepatoblastoma.

Authors:  Tomoro Hishiki
Journal:  Int J Clin Oncol       Date:  2013-10-17       Impact factor: 3.402

Review 7.  Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.

Authors:  Taizo Hibi; Masahiro Shinoda; Osamu Itano; Yuko Kitagawa
Journal:  Organogenesis       Date:  2014-05-16       Impact factor: 2.500

8.  Morbidity and mortality associated with liver resections for primary malignancies in children.

Authors:  Nathan P Zwintscher; Kenneth S Azarow; John D Horton
Journal:  Pediatr Surg Int       Date:  2014-03-20       Impact factor: 1.827

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.